Outbreak-related mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 1, 2014, Pages 140-145

  Takla, Anja ^a,b   Boḧmer, Merle M ^a,b,c   Klinc, Christina ^c   Kurz, Norbert ^d   Schaffer, Alice ^d   Stich, Heribert ^e   Stoc̈ker, Petra ^c   Wichmann, Ole ^a   Koch, Judith ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^c Bavarian Health and Food Safety Authority LGL   (Germany)

^d Public Health Authority   (Germany)

^e Public Health Authorities District of Erding   (Germany)

Author keywords

Adults; Cohort study; Germany; MMR vaccine; Mumps; Vaccine effectiveness

Indexed keywords

MUMPS VACCINE;

ADULT; ARTICLE; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFICACY; EPIDEMIC; FEMALE; GERMANY; HUMAN; ICE HOCKEY; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MUMPS; PRESCHOOL CHILD; PRIMARY SCHOOL; QUESTIONNAIRE; RETROSPECTIVE STUDY; REVACCINATION; SAMPLE SIZE; SCHOOL CHILD; YOUNG ADULT;

EID: 84896700279     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.26642     Document Type: Article

References (37)

1. Hviid A, Rubin S, Mühlemann K. Mumps. Lancet 2008; 371:932-44; PMID:18342688; http://dx.doi.org/10.1016/S0140-6736(08)60419-5
2. Rubin S, Plotkin SA. Mumps vaccine. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 6 ed. Philadelphia PA: Saunders; 2013. p. 419-46.
3. Heymann D, ed. Control of Communicable Diseases Manual. 19th ed. Washington, DC: American Public Health Association; 2008.
4. Yung CF, Andrews N, Bukasa A, Brown KE, Ramsay M. Mumps complications and effects of mumps vaccination, England and Wales, 2002-2006. Emerg Infect Dis 2011; 17:661-7, quiz 766; PMID:21470456; http://dx.doi.org/10.3201/eid1704. 101461
5. Eriksen J, Davidkin I, Kafatos G, Andrews N, Barbara C, Cohen D, Duks A, Griskevicius A, Johansen K, Bartha K, et al. Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations? Epidemiol Infect 2012; 141:1-16; PMID:22687578
6. Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L. Measles, mumps, and rubella - vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1998; 47(RR-8):1-57; PMID:9639369
7. Public Health Agency of Canada. Statement on Mumps Vaccine. http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/07vol33/acs-08/index-eng.php. Accessed 12 November 2012.
8. Koch J, Takla A. [Effects of the MMR vaccination on the epidemiology of mumps in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013; 56:1305-12; PMID:23990094; http://dx.doi.org/10.1007/s00103-013-1784-4
9. Hilleman MR, Weibel RE, Buynak EB, Stokes J Jr., Whitman JE Jr. Live attenuated mumps-virus vaccine. IV. Protective efficacy as measured in a field evaluation. N Engl J Med 1967; 276:252-8; PMID:6016061; http://dx.doi.org/10. 1056/NEJM196702022760502
10. Sugg WC, Finger JA, Levine RH, Pagano JS. Field evaluation of live virus mumps vaccine. J Pediatr 1968; 72:461-6; PMID:4869563; http://dx.doi.org/10. 1016/S0022-3476(68)80334-8
11. Dayan GH, Rubin S. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks? Clin Infect Dis 2008; 47:1458-67; PMID:18959494; http://dx.doi.org/10.1086/591196
12. Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C. Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev 2012; 2:CD004407; PMID:22336803
13. Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, Hunt K, Finley CG, Leschinsky DP, O'Keefe AL, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008; 358:1580-9; PMID:18403766; http://dx.doi.org/10.1056/NEJMoa0706589
14. Marin M, Quinlisk P, Shimabukuro T, Sawhney C, Brown C, Lebaron CW. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students - Iowa, 2006. Vaccine 2008; 26:3601-7; PMID:18539365; http://dx.doi.org/10.1016/j.vaccine.2008.04.075
15. Barskey AE, Schulte C, Rosen JB, Handschur EF, Rausch-Phung E, Doll MK, Cummings KP, Alleyne EO, High P, Lawler J, et al. Mumps outbreak in Orthodox Jewish communities in the United States. N Engl J Med 2012; 367:1704-13; PMID:23113481; http://dx.doi.org/10.1056/NEJMoa1202865
16. Brockhoff HJ, Mollema L, Sonder GJB, Postema CA, van Binnendijk RS, Kohl RHG, de Melker HE, Hahné SJ. Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004. Vaccine 2010; 28:2932-6; PMID:20188683; http://dx.doi.org/10.1016/j.vaccine.2010.02.020
17. Whelan J, van Binnendijk R, Greenland K, Fanoy E, Khargi M, Yap K, Boot H, Veltman N, Swaan C, van der Bij A, et al. Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010. Euro Surveill 2010; 15:19554; PMID:20460086
18. Boxall N, Kubínyiová M, Príkazský V, Beneš C, Cástková J. An increase in the number of mumps cases in the Czech Republic, 2005-2006. Euro Surveill 2008; 13:1-4; PMID:18768117
19. Anis E, Grotto I, Moerman L, Warshavsky B, Slater PE, Lev B. Mumps outbreak in Israel's highly vaccinated society: are two doses enough? Epidemiol Infect 2012; 140:439-46; PMID:21554780; http://dx.doi.org/10.1017/ S095026881100063X
20. Stein-Zamir C, Shoob H, Abramson N, Tallen-Gozani E, Sokolov I, Zentner G. Mumps outbreak in Jerusalem affecting mainly male adolescents. Euro Surveill 2009; 14:19440; PMID:20070937
21. Peltola H, Kulkarni PS, Kapre SV, Paunio M, Jadhav SS, Dhere RM. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clin Infect Dis 2007; 45:459-66; PMID:17638194; http://dx.doi.org/10. 1086/520028
22. Poethko-Müller C, Mankertz A. Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity. PLoS One 2012; 7:e42867; PMID:22880124; http://dx.doi.org/10.1371/journal.pone.0042867
23. Robert Koch Institute. Mumps outbreak at a primary school in Nuremberg 2011 - exemplary description of the outbreak management and intended changes of the STIKO recommendation regarding occupational mumps vaccination [in German]. EpiBull 2012; 22:205-11
24. Takla A, Wichmann O, Klinc C, Hautmann W, Rieck T, Koch J. Mumps epidemiology in Germany 2007-11. Euro Surveill 2013; 18:20557; PMID:23968877; http://dx.doi.org/10.2807/1560-7917.ES2013.18.33.20557
25. Otto W, Mankertz A, Santibanez S, Saygili H, Wenzel J, Jilg W, Wieland W, Borgmann S. Ongoing outbreak of mumps affecting adolescents and young adults in Bavaria, Germany, August to October 2010. Euro Surveill 2010; 15:19748; PMID:21172171
26. Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, Brown D, Ramsay ME. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 2007; 13:12-7; PMID:17370510; http://dx.doi.org/10.3201/ eid1301.060649
27. Schaffzin JK, Pollock L, Schulte C, Henry K, Dayan G, Blog D, Smith P. Effectiveness of previous mumps vaccination during a summer camp outbreak. Pediatrics 2007; 120:e862-8; PMID:17908742; http://dx.doi.org/10.1542/peds.2006- 3451
28. Robert Koch Institute. Vaccination coverage rates at school entry in 2010 [in German]. EpiBull 2012; 16:135-9
29. Deeks SL, Lim GH, Simpson MA, Gagné L, Gubbay J, Kristjanson E, Fung C, Crowcroft NS. An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada. CMAJ 2011; 183:1014-20; PMID:21576295; http://dx.doi.org/10.1503/cmaj.101371
30. Stehr K, Heininger U. State of vaccination in the Western federal states [in German]. Dtsch Arztebl 1991; 88:1986-91
31. Robert Koch Institute. Recommendations of the Standing Committee on Vaccinations (STIKO) at the Robert Koch Institute / Effective: July 2011. http://www.rki.de/EN/Content/Prevention/Vaccination/recommandations/ STIKO-Recommendations-2011-en.pdf ?-blob=publicationFile. Accessed 1 August 2012.
32. Davidkin I, Kontio M, Paunio M, Peltola H. MMR vaccination and disease elimination: the Finnish experience. Expert Rev Vaccines 2010; 9:1045-53; PMID:20822347; http://dx.doi.org/10.1586/erv.10.99
33. Date AA, Kyaw MH, Rue AM, Klahn J, Obrecht L, Krohn T, Rowland J, Rubin S, Safranek TJ, Bellini WJ, et al. Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Infect Dis 2008; 197:1662-8; PMID:18419346; http://dx.doi.org/10.1086/588197
34. Vandermeulen C, Roelants M, Vermoere M, Roseeuw K, Goubau P, Hoppenbrouwers K. Outbreak of mumps in a vaccinated child population: a question of vaccine failure? Vaccine 2004; 22:2713-6; PMID:15246601; http://dx.doi.org/10.1016/j.vaccine.2004.02.001
35. Ogbuanu IU, Kutty PK, Hudson JM, Blog D, Abedi GR, Goodell S, Lawler J, McLean HQ, Pollock L, Rausch-Phung E, et al. Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak. Pediatrics 2012; 130:e1567-74; PMID:23129075; http://dx.doi.org/10.1542/peds.2012-0177
36. CDC. Chapter 9: Mumps. Manual for the Surveillance of Vaccine-Preventable Diseases. 2012. http://www.cdc.gov/vaccines/pubs/surv-manual/chpt09-mumps.html. Accessed 13 February 2013.
37. Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, Sirotkin B. Field evaluation of vaccine efficacy. Bull World Health Organ 1985; 63:1055-68; PMID:3879673